ライフサイエンスコーパス: PCT

1 PCT and CRP demonstrated to have a good negative predict

2 PCT appears to be a reliable indicator of infection.

3 PCT associated with URO-D mutations is designated famili

4 PCT has also been studied in patients with sepsis in an

5 PCT has been studied as a diagnostic marker in different

6 PCT has performed better than C-reactive protein in some

7 PCT is a reliable serum marker for determining the prese

8 PCT is more efficient and general than conventional tran

9 PCT may aid in diagnosing infection in challenging patie

10 PCT use was associated with increased antibiotic-days (a

11 PCT use was not associated with improved antibiotic use

12 PCT was <0.25 ng/mL in 19 (63.3%) patients.

13 PCT was also found to allow for unambiguous control of d

14 PCT was measured daily while in the ICU.

15 PCT was optimized for pressure and time, and it was foun

16 PCTs exhibited a 5.5 times higher mutant frequency in la

17 PCTs placed from April 1, 1998, to December 31, 2009 (ti

18 PCTs were carried forward to GWAS ( approximately 2.5 mi

19 ons were fewer following PCT platelets (3.0% PCT versus 4.4% control; P =.02).

20 the incidence of grade 3 or 4 bleeding (4.1% PCT versus 6.1% control), were equivalent between the 2

21 to and partially redundantly with the CYY-1/PCT-1 pathway.

22 Primary analysis included 196 (PCT) versus 198 standard care patients.

23 ment of six biomarkers (IL-6, nCD64, IL-1ra, PCT, MCP1, and G-CSF) yielded the same predictive power

24 orrected count increment (CCI) (11.1 x 10(3) PCT versus 16.0 x 10(3) control), average number of days

25 A total of 645 patients (318 PCT and 327 control) were evaluated.

26 l), and number of platelet transfusions (8.4 PCT versus 6.2 control) were different (P <.001).

27 nt, the incidence of grade 2 bleeding (58.5% PCT versus 57.5% control), and the secondary end point,

28 er of days to next platelet transfusion (1.9 PCT versus 2.4 control), and number of platelet transfus

29 A PCT algorithm, including 0.1 ng/ml cut-off, determined a

30 35 of 53 days (66.0%) when the patient had a PCT less than 50000/muL and on 203 of 436 days (46.6%) w

31 3 of 436 days (46.6%) when the patient had a PCT of 50000/muL to 99000/muL.

32 l adults with undifferentiated infections, a PCT algorithm including 0.1 ng/ml cut-off did not achiev

33 recognize Cr(3+) in aqueous medium through a PCT mechanism.

34 The admission PCT (p = .0002) and TNF levels (p = .0001) were higher i

35 In survivors and nonsurvivors, the admission PCT was 82 ng/mL vs. 273 ng/mL (p = .03), IL-10 was 62 p

36 y-nine patients (22%) achieved ALN pCR after PCT.

37 Mortality rates after PCT decreased over time.

38 cterial tests were positive in 64 (18%), and PCT analysis identified bacterial infection in an additi

39 cates the cyclin-dependent kinases CDK-5 and PCT-1 and the cyclin CCY-1 in the regulation of the micr

40 CRP and PCT are the most promising, but neither is an ideal sing

41 od count (WBC), C-reactive protein (CRP) and PCT levels were measured in 3rd and 5th postoperative da

42 understand the competition between FRET and PCT.

43 ficant association between HCV infection and PCT, lichen planus, vitiligo, cryoglobulinemia, membrano

44 ProADM and PCT have promising roles in assisting clinicians in mana

45 ProADM and PCT levels were measured at onset of fever and then on d

46 The initial proADM and PCT levels were significantly higher in neutropenic pati

47 Follow-up, proADM, and PCT levels decreased significantly in response to antimi

48 Combination anthracycline/taxane-based PCT resulted in significantly more ALN pCRs, although ou

49 d States and to examine associations between PCT use and clinical outcomes.

50 e to dendrites in animals defective for both PCT-1 and CDK-5 pathways.

51 expressed at significantly higher levels by PCT were a number involved in NOTCH signaling, a finding

52 the intrasession repeatability of ACD, CCT, PCT at different nasal and temporal locations, WTW, and

53 ry breast tumors after primary chemotherapy (PCT) is associated with higher relapse-free survival (RF

54 ed with patients undergoing cholecystectomy, PCT patients had a higher rate of cardiovascular disease

55 Clinically, PCT levels may help in decisions regarding the need for

56 The objective of this study was to compare PCT and cholecystectomy outcomes over time.

57 Current PCT assays are rapid, specific, and of sufficient sensit

58 sphate: phosphocholine cytidylyltransferase (PCT), S-adenosylmethionine (SAM), and S-adenosylhomocyst

59 We sought to determine PCT use in critically ill patients with sepsis in the Un

60 sis gene (Uro-d(+/-), Hfe(-/-)) that develop PCT with no treatments.

61 chow (440 micro g of selenium/kg) developed PCT by 275 days postpristane.

62 Furthermore, the developed PCT assay can be applied in whole human blood with an ad

63 e CriSTAL criteria tool to encourage earlier PCT referrals.

64 The study indicates a need for earlier PCT referral, showcases the potential to identify high r

65 transplantation, were transfused with either PCT-FFP or C-FFP for up to 7 days.

66 A subset of PCT, designated extramedullary PCT, is distinguished from multiple myeloma and solitary

67 ngs provide a unique model of extramedullary PCT for studies on pathogenesis and treatment and sugges

68 Extramedullary (extraosseus) PCT are rare spontaneous neoplasms of mice but are readi

69 ees with familial porphyria cutanea tarda (F-PCT).

70 URO-D mutations occurring in patients with F-PCT.

71 with URO-D mutations is designated familial PCT.

72 ) locus has been developed to mimic familial PCT in humans.

73 use serves as an excellent model of familial PCT and affords the opportunity to define the mechanism

74 Transfusion reactions were fewer following PCT platelets (3.0% PCT versus 4.4% control; P =.02).

75 operating characteristic curve was 0.73 for PCT, 0.67 for IL-10, and 0.76 for TNF, compared with 0.8

76 days to next transfusion were decreased for PCT compared with conventional platelets.

77 dence of grade 2 bleeding was equivalent for PCT and conventional platelets, although posttransfusion

78 Using a cutoff value of 0.3 ng/mL for PCT and 20 mg/L for CRP, negative likelihood ratios were

79 To investigate this hypothesis, we generated PCTs that harbored the transgenic shuttle vector, pUR288

80 re identified in 42% (63), and 83% (126) had PCT values of <0.25 microg/mL.

81 with PCT available, 3769 (18%) patients had PCT levels checked; 1119 (29.7%) had serial PCT measurem

82 ater proportion of HCV-infected patients had PCT, vitiligo, lichen planus, and cryoglobulinemia.

83 oradiologists evaluated NCT for hypodensity, PCT for infarct core and salvageable brain tissue, and C

84 proximately 2.5 million markers) to identify PCT-associated loci among 975 European American adult pa

85 More importantly, PCT cycle analysis demonstrated that the MgH(2)-0.1TiH(2

86 this pathway, NOTCH signaling was blocked in PCT cell lines by treatment with a gamma-secretase inhib

87 Changes in PCT at the 12-o'clock position and best spectacle-correc

88 helial transport, were inversely enriched in PCT and mTAL.

89 equential PCT measurements showed no fall in PCT after 24 hrs treatment.

90 patic siderosis, a nearly uniform finding in PCT.

91 ufficient sensitivity to detect increases in PCT serum levels within 4 to 6 h of initiation of infect

92 n of these genes influenced iron overload in PCT, we compared sequences of HAMP and HJV in 96 patient

93 lysis implicated several genetic pathways in PCT progression, including biphasic (up- and then down-r

94 capture microdissection to collect incipient PCT cells and analyzed their global gene expression on A

95 ns, in the promotion of inflammation-induced PCT and suggest that small drug inhibitors of selenoprot

96 CS fates, and suggest that sim1a may inhibit PCT fate and/or negotiate the PCT/PST boundary.

97 Response to initial PCT has important potential as a guide to subsequent the

98 t decrease in mean (95% confidence interval) PCT change over time (-2.18 [-2.97 to -1.40 mum/year] an

99 YY-1) and a cyclin-dependent Pctaire kinase (PCT-1) necessary for targeting presynaptic components to

100 nd positive culture, the decline rate in log(PCT) over the first 72 hours independently predicted hos

101 th positive results of viral testing and low PCT values who were discharged receiving antibiotics (20

102 Recently, it has been shown that many PCT patients carry mutations in the HFE gene, which is r

103 8 to -0.67 mum/year], respectively) and mean PCT percent change over time (-3.32% [-4.36 to -2.27 mum

104 At baseline, the global mean PCT was significantly thinner in glaucoma patients than

105 ellent model for studies of alcohol-mediated PCT.

106 there is no probe self-quenching and minimum PCT, efficient signal amplification is demonstrated desp

107 le in controlling Akt activity in both mouse PCT and NIH3T3 fibroblast lines by using anti-sense olig

108 ranslocated Myc in the pathogenesis of mouse PCT, two signaling pathways also implicated in developme

109 with delayed-onset ADA-SCID using tandem-MS (PCT EP2010/070517) to evaluate levels of adenosine and 2

110 wn-regulation and overexpression in myeloma, PCT and NIH3T3 lines and analysed Akt activation.

111 We were able to detect native PCT in patient samples and showed a good correlation (R(

112 tion who were evaluated on admission by NCT, PCT, and CTA, and underwent a follow-up CT/CTA or magnet

113 ictably high incidence (approximately 85% of PCT), and has a direct counterpart in humans: Burkitt ly

114 Abrogation of PCT was caused in part by the striking inhibition of the

115 The addition of PCT levels to bacterial culture and viral detection resu

116 Analysis of PCT use by instrumental variable and difference-in-diffe

117 odels were used to determine associations of PCT use with outcomes (antibiotic-days, incidence of Clo

118 acute stroke is afforded by a combination of PCT and CTA.

119 nephrons that were predominantly composed of PCT segments, but lacked the enlarged PST observed in RA

120 Serum concentrations of PCT and sTREM-1 and the PMN CD64 index were higher in pa

121 state of the art device for the detection of PCT.

122 is gene (HFE) mutations in the expression of PCT and to determine the contribution of acquired factor

123 the greatest risk factors for expression of PCT, and in most patients, more than 1 risk factor was i

124 ndings suggested that the hypermutability of PCT is governed mainly by intrinsic features of tumor ce

125 Programs to improve implementation of PCT-based strategies are warranted prior to widespread a

126 totally refractory to pristane induction of PCT.

127 kidney disease may alter baseline levels of PCT and thus result in inappropriate use of PCT in this

128 Low levels of PCT, together with low CRP values, seem to be early and

129 may have implications for the management of PCT.

130 further investigations into the mechanism of PCT.

131 In this mouse model of PCT, AA suppresses hepatic URO accumulation at low, but

132 cytosolic extracts from two murine models of PCT: wild-type mice treated with iron, delta-aminolevuli

133 The gene expression profiles of PCT samples and those of undissected OG samples from adj

134 haracterized the transcriptional profiles of PCT, centroblastic diffuse large B-cell lymphomas (CBL),

135 ts and glaucoma patients in the mean rate of PCT change (P = .28) or PCT percentage change over time

136 to determine whether monitoring the rate of PCT change has a role in glaucoma management.

137 The rate of PCT thinning was calculated using mixed effects models.

138 This report of PCT detection is first of its kind among the electronic

139 ucted to evaluate the efficacy and safety of PCT-FFP compared with conventional FFP (C-FFP).

140 A subset of PCT, designated extramedullary PCT, is distinguished fro

141 strikingly similar and quite unlike that of PCT.

142 The presence and timing of PCT referral as well as patient survival status to hospi

143 However, current use of PCT and associated outcomes in real-world clinical setti

144 This article focuses on the use of PCT in patients with various degrees of chronic kidney d

145 PCT and thus result in inappropriate use of PCT in this population.

146 The characteristic features of PCTs are that they (1) select clinically relevant altern

147 The supply of PCTs is limited primarily because the major funders of c

148 Increasing the supply of PCTs will depend on the development of a mechanism to es

149 %; SP = 97%), Increased mean transit time on PCT was predictive of the tissue at risk for infarction

150 Decreased cerebral blood volume on PCT was the most accurate predictor of final infarct vol

151 in the mean rate of PCT change (P = .28) or PCT percentage change over time (P = .23).

152 t a ratio of 1:1 to receive standard care or PCT-guided care and viral PCR testing.

153 han WBC but less accurate than either CRP or PCT.

154 1 experimental design (PDX clinical trial or PCT) to assess the population responses to 62 treatments

155 inactivate pathogens in fresh frozen plasma (PCT-FFP).

156 and heavy chain diseases, and plasmacytoma (PCT).

157 interleukin 6-dependent mouse plasmacytoma (PCT), is the premier model of cancer-associated chromoso

158 nslocations characteristic of plasmacytomas (PCT), little is known about genetic factors and signalin

159 ns, T(12;15), in BALB/c mouse plasmacytomas (PCTs).

160 Previous work on peritoneal plasmacytomas (PCTs) in mice suggested that PCTs have a mutator phenoty

161 Peritoneal plasmacytomas (PCTs) in strain BALB/c (C), the premier experimental mod

162 curve for biomarkers shows that in 3rd POD, PCT and CRP have similar area under the curve (AUC) (0.7

163 ), both better than WBC (0.601); in 5th POD, PCT has a better AUC than CRP and WBC (0.862 vs 0.806 vs

164 mbination of rituximab and polychemotherapy [PCT]), and outcome were recorded.

165 The pretransfusion PCT was at least 50000/muL for 653 of 998 transfusions (

166 ent of transformed plasma cells in a primary PCT also induced apoptosis.

167 Procalcitonin (PCT) has been shown to be a useful surrogate marker in i

168 Procalcitonin (PCT) is increasingly utilized to determine the presence

169 Procalcitonin (PCT) is synthesized by a large number of tissues and org

170 myeloid cells-1 (sTREM-1) and procalcitonin (PCT) were assayed, and the expression of the high-affini

171 C), C-reactive protein (CRP), procalcitonin (PCT), and interleukin-6 (IL-6).

172 -6, C-reactive protein (CRP), procalcitonin (PCT), and soluble urokinase plasminogen activator recept

173 bservational study to test if Procalcitonin (PCT) might be an early and reliable marker of anastomoti

174 protein (CRP) (2-200 mug/mL), procalcitonin (PCT) (0.2-50 ng/mL), and interleukin 6 (IL-6) (2-2000 pg

175 measuring the serum level of procalcitonin (PCT) as a marker of bacterial infection.

176 eveloped for the detection of procalcitonin (PCT), a sepsis marker.

177 eveloped for the detection of procalcitonin (PCT), a specific and early marker for sepsis and microbi

178 The role of procalcitonin (PCT), a widely used sepsis biomarker, in critically ill

179 domized trials support use of procalcitonin (PCT)-based algorithms to decrease duration of antibiotic

180 tudies suggest that the serum procalcitonin (PCT) level may be used to guide antibiotic therapy.

181 nary antigen tests, and serum procalcitonin (PCT) were done in nearly all cases.

182 The procalcitonin (PCT) assay is an accurate screening test for identifying

183 h recent growing attention to procalcitonin (PCT) and pro-adrenomedullin (proADM).

184 metastases were treated in five prospective PCT trials.

185 Moreover, human recombinant PCT (hrPCT) for use as a standard was developed in the n

186 tively, in patients who received a rituximab-PCT regimen compared with 48% and 38% in those who recei

187 teristics during both periods, but rituximab-PCT regimens were administered to 88.5% of the patients

188 s a result of the use of intensive rituximab-PCT regimens in most patients, including very elderly on

189 ariate analysis, treatment without rituximab-PCT was the only adverse prognostic factor (odds ratio,

190 Sequential PCT levels were available at 0 hrs and 24 hrs in 39 pati

191 Of 39 children, 16 (41%) with sequential PCT measurements showed no fall in PCT after 24 hrs trea

192 PCT levels checked; 1119 (29.7%) had serial PCT measurements.

193 Antibiotic therapy tailored to serial PCT measurements may shorten the antibiotic exposure wit

194 a positive bacterial assay result or a serum PCT level of >/= 0.25 ng/mL on admission or day 2 of hos

195 e diagnostic and prognostic utility of serum PCT in children.

196 Recent studies endorse the use of serum PCT to detect invasive infection, to differentiate sepsi

197 We identified six PCTs with distinct microbial community/IL-1beta structur

198 inguished from multiple myeloma and solitary PCT of bone by its distribution among various tissue sit

199 The presence of such fingerprints in some PCTs suggests that the tumors sometimes evolve from tran

200 betes drug, metformin, was a potent specific PCT inhibitor in vitro.

201 These results suggest PCT-FFP supported hemostasis in the treatment of acquire

202 own to enhance both porphyria cutanea tarda (PCT) and experimental uroporphyria.

203 or risk factors for porphyria cutanea tarda (PCT) are alcohol consumption and homozygosity for the C2

204 the development of porphyria cutanea tarda (PCT) are alcohol consumption and homozygosity for the C2

205 Porphyria cutanea tarda (PCT), a liver disease with skin lesions caused by excess

206 Porphyria cutanea tarda (PCT), the most common form of porphyria in humans, is du

207 rd of patients with porphyria cutanea tarda (PCT), the most common porphyria in humans, inherit a sin

208 on in patients with porphyria cutanea tarda (PCT).

209 c manifestations of porphyria cutanea tarda (PCT).

210 porphyria (AIP) and porphyria cutanea tarda (PCT).

211 involving the skin (porphyria cutanea tarda [PCT], vitiligo, and lichen planus); renal (membranous gl

212 New rat monoclonal antibodies targeting PCT were screened and characterized.

213 duled to meet with the palliative care team (PCT) and complete quality-of-life (QOL) and mood questio

214 l to stimulate earlier Palliative Care Team (PCT) referral served as an underlying goal, and investig

215 ion complicated with posterior capsule tear (PCT) may be associated with severe complications.

216 l by the use of pressure-cycling technology (PCT) to increase the speed and decrease the relative amo

217 , also known as pressure cycling technology (PCT), using a Barocycler NEP 2320 was compared with the

218 hat is based on pressure cycling technology (PCT).

219 Pressure-composition-temperature (PCT) analysis demonstrated that both the nanosize and th

220 Our objective was to demonstrate that PCT provides more controlled enzymatic digestion of prot

221 In this study we have shown that PCT-treated T cells that are cytotoxic but nonproliferat

222 In addition, our results suggest that PCTs may represent a more accurate approach than cell li

223 plasmacytomas (PCTs) in mice suggested that PCTs have a mutator phenotype caused by Myc-deregulating

224 The PCT approach performed at least as well as the conventio

225 The PCT assay has better diagnostic accuracy than CRP measur

226 The PCT assay offered an area under the curve (AUC) of ROC c

227 The PCT Shredder is a mechanical grinder that quickly breaks

228 RNA restores localization of TbetaRII at the PCT cell surface, indicating a ligand-induced impediment

229 These methods use the Barocycler, the PCT Shredder, or both.

230 In conclusion, the PCT method was found to be much faster than using atmosp

231 nction studies, sim1a knockdown expanded the PCT and abrogated both the PST and CS populations.

232 C ROC curve for the detection of IBI for the PCT assay was significantly higher than that for the CRP

233 ntracellular binding of active ligand in the PCT and restores cell surface expression of the endogeno

234 now demonstrate that active TGF-beta1 in the PCT binds to intracellular TGF-beta type II receptor (Tb

235 of 35 (18%) versus 31 (16%), P = 0.54 in the PCT versus standard care, respectively.

236 All practices in the PCT were invited to the LES initiative, which ensured av

237 1a may inhibit PCT fate and/or negotiate the PCT/PST boundary.

238 The diagnostic characteristics of the PCT assay, C-reactive protein (CRP) concentration, white

239 hanism underlying clinical expression of the PCT phenotype, namely oxidation of uroporphyrinogen to u

240 functionality, enabling combinations of the PCT Shredder and the Barocycler to be used to purify mit

241 to be present on the apical membrane of the PCT.

242 terial infection (IBI); however, data on the PCT assay in very young infants are insufficient.

243 xpanded the PST and CS, while it reduced the PCT.

244 immunosensor showed high selectivity to the PCT analyte which was evident through control experiment

245 Mitochondria isolated using the PCT Shredder are shown to be comparable to controls.

246 bility requirements by both meeting with the PCT and completing QOL assessments at least 50% of the t

247 Four of the PCTs that developed in the newly generated translocation

248 ed naive T cells with photochemical therapy (PCT) using S-59 psoralen and UVA light to prevent prolif

249 d measure peripapillary choroidal thickness (PCT) from circle scans centered on the optic nerve head.

250 ness (CCT) and peripheral corneal thickness (PCT), and Scheimpflug imaging calculating corneal volume

251 tral (CCT) and peripheral corneal thickness (PCT), white-to-white diameter (WTW), and irido-corneal a

252 patient-days (93.4%) with thrombocytopenia (PCT, <100000/muL) when a platelet transfusion was given

253 Thus, PCT-1 and CDK-5 pathways direct polarized trafficking of

254 To directly test the contribution of IL-6 to PCT development, we generated BALB/c mice carrying a wid

255 Tailoring antibiotics to PCT levels may reduce the duration of therapy without in

256 ulating Myc in a manner that is conducive to PCT development.

257 This study compares proADM to PCT as diagnostic and prognostic biomarkers of infection

258 Antibodies specific to PCT were immobilized on the poly-3-hexylthiophene (P3HT)

259 Measuring together PCT and CRP significantly improves AL diagnosis in 5th P

260 beta) and derive periodontal complex traits (PCTs) via principal component analysis.

261 emonstrate a polymerase chain transcription (PCT) reaction that results in the exponential production

262 involvement of photoinduced charge transfer (PCT) as an energy wasting mechanism.

263 e mechanism of photoinduced charge transfer (PCT).

264 , over half developed readily transplantable PCT in lymph nodes, Peyer's patches, and sometimes splee

265 cZ mutant frequency in serially transplanted PCTs and phagocyte-induced lacZ mutations in B cells in

266 d to receive either photochemically treated (PCT) or conventional (control) platelets for up to 28 da

267 An ex vivo photochemical treatment (PCT) process was developed to inactivate pathogens in fr

268 lled pragmatic or practical clinical trials (PCTs).

269 Percutaneous cholecystostomy tube (PCT) placement serves as a treatment option for acute ch

270 The proximal convoluted tubule (PCT) and the medullary thick ascending limb (mTAL) in th

271 The proximal convoluted tubule (PCT) reabsorbs most of the filtered bicarbonate.

272 he proximal convoluted and straight tubules (PCT, PST).

273 We extracted nascent plasma cell tumor (PCT) cells from within inflammatory oil granulomas (OG)

274 In contrast, mouse plasma cell tumor (PCT) lines, expressing wild type PTEN, did not respond t

275 studied pristane-induced plasma cell tumors (PCTs).

276 eased from 36% to 12% in patients undergoing PCT (P = 0.001).

277 h the first time period, patients undergoing PCT in the second time period had lower American Society

278 total of 143 patients successfully underwent PCT placement in time period 2.

279 d a trial assessing the feasibility of using PCT algorithms with viral testing to guide antibiotic us

280 bacterial from nonbacterial pneumonia using PCT has shown to reduce antibiotic usage, length of stay

281 ormation of the inflammatory tissue in which PCT develop (pristane granuloma).

282 ty and negative predictive value for AL with PCT less than 2.7 and 2.3 ng/mL were, respectively, 91.7

283 e that the hepatic siderosis associated with PCT likely results from dysregulated HAMP.

284 otic or outcome improvements associated with PCT use.

285 l B cell lymphomas that often coexisted with PCT.

286 There has been very limited experience with PCT in this country, however.

287 l patients with sepsis in 107 hospitals with PCT available, 3769 (18%) patients had PCT levels checke

288 transfusions were given to VLBW infants with PCT greater than 50000/muL.

289 equences of HAMP and HJV in 96 patients with PCT and 88 HFE C282Y homozygotes with marked hepatic iro

290 on-related genes in a group of patients with PCT and hh.

291 Hepatic HAMP expression in patients with PCT was significantly reduced, regardless of HFE genotyp

292 ay a contributory role in some patients with PCT, NASH, or chronic HCV.

293 This study, comprising 108 patients with PCT, was intended to define the role of hemochromatosis

294 cts of liver biopsy samples of patients with PCT.

295 aled exonic polymorphisms in 2 patients with PCT: heterozygosity for a G-->A transition (G71D substit

296 ents, who underwent phacoemulsification with PCT and sulcus implantation of SPA-IOL designed for both

297 liary sulcus during phacoemulsification with PCT rather than switching to another backup IOL demandin

298 e combining the PMN CD64 index together with PCT and sTREM-1 serum levels in diagnosing sepsis in the

299 nsitized to BALB/c splenocytes, treated with PCT, and coinjected with TCDBM, there was a partial rest

300 n compared with patients with hh but without PCT with comparable iron overload.